You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IV survival

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ischemic Stroke, Thrombolytic (t-PA) Treatment, Gender Bias Trial in Barcelona (IV thrombolytic (t-PA) treatment vs not)

Completed
  • Ischemic Stroke
  • +3 more
  • IV thrombolytic (t-PA) treatment vs not
  • Barcelona, Spain
    Plan Director Enfermedad Vascular Cerebral
Apr 3, 2022

Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

Recruiting
  • Breast Cancer Stage IV
  • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
  • Mansoura, Dakahlia, Egypt
    Oncology center mansoura university
Jan 1, 2023

Colorectal Cancer Metastatic, Chemo Trial in France (Oncogramme®)

Recruiting
  • Colorectal Cancer Metastatic
  • Chemotherapy
  • Oncogramme®
  • Amiens, France
  • +13 more
Sep 10, 2022

NSCLC Trial in Rozzano (Pemetrexed/Carboplatin, Gemcitabine)

Terminated
  • NSCLC
  • Rozzano, Milan, Italy
    Istituto Clinco Humanitas
Sep 8, 2022

The Study Will Focus on Assessing the Survival Benefit on an Enhanced Package of Care for Patients With Advanced HIV Disease

Recruiting
  • The Study Will Focus on Assessing the Survival Benefit on an Enhanced Package of Care for Patients With Advanced HIV Disease
  • Enhanced care package
  • Kampala, Uganda
    kisugu health center IV
Jul 9, 2022

Survival Analysis of Oral Cancer Patients

Completed
  • Head and Neck Cancer
  • tumor resection and mandible reconstruction
  • Leuven, Belgium
    UZ Leuven
Jul 15, 2021

Internal Mammary or Supraclavicular Lymphadenectomy

Recruiting
  • Ovarian Cancer Stage IV
  • Lymph Node Metastases
  • debulking surgery
  • Seoul, 시/도/주, Korea, Republic of
    Seoul National University Hospital
Aug 10, 2021

Breast Cancer Stage IV Trial in Tehran (Systemic therapy followed by surgery if the disease is not progressive)

Recruiting
  • Breast Cancer Stage IV
  • Systemic therapy followed by surgery if the disease is not progressive
  • Tehran, Iran, Islamic Republic of
    Tehran University of Medical Sciences
Jan 5, 2021

Catheter Complications Trial in Royal Oak (Standard Long IV 4.78 cm 20 g catheter, Ultra-Long IV 6.35 cm 20 g catheter)

Completed
Has Results
  • Catheter Complications
  • Standard Long IV 4.78 cm 20 g catheter
  • Ultra-Long IV 6.35 cm 20 g catheter
  • Royal Oak, Michigan
    Beaumont Hospitals
Feb 26, 2020

Advanced IIIB-IV Squamous Cell Lung Cancer Receiving PD-1

Unknown status
  • Lung Squamous Cell Carcinoma Stage IV
  • Nivolumab or Pembrolizumab
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Mar 11, 2020

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +21 more
  • Atezolizumab
  • +8 more
  • Little Rock, Arkansas
  • +97 more
Jan 27, 2023

Stage IV Breast Cancer Survival Time and Remission.

Unknown status
  • Breast Cancer
  • laboratory biomarker analysis
  • therapeutic dietary intervention
  • Spokane Valley, Washington
    Brabant Research, Incorporated
Jan 14, 2020

Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Tumors Germ Cell and Embryonal Tumors by Histologic Type Tumors Tumors

Not yet recruiting
  • Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
  • HX008 + TACE
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer hospital
Dec 8, 2022

Melanoma Stage III Trial in North Sydney (Pembrolizumab, Lenvatinib)

Recruiting
  • Melanoma Stage III
  • North Sydney, New South Wales, Australia
    Melanoma Institute Australia
Oct 26, 2022

Non Small Cell Lung Cancer Trial in Ostrava (Chemotherapy, Radiotherapy (RT) + Stereotactic Body Ratio Therapy (SBRT),

Recruiting
  • Non Small Cell Lung Cancer
  • Chemotherapy
  • +2 more
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Dec 19, 2022

Melanoma Trial in Nedlands, Haifa, Jerusalem (Pembrolizumab/Vibostolimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Pembrolizumab/Vibostolimab
  • Pembrolizumab
  • Nedlands, Western Australia, Australia
  • +2 more
Jan 31, 2023

Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

Recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • CYNK-001 systemic and Intra cavity administration
  • Duarte, California
  • +5 more
Jan 20, 2023

HER2-positive Early Breast Cancer Trial in Germany (Trastuzumab deruxtecan, Standard-of-Care)

Not yet recruiting
  • HER2-positive Early Breast Cancer
  • Munich, Bavaria, Germany
  • +11 more
Jan 19, 2023

Metastatic Castration-resistant Prostate Cancer Trial (ONC-392, lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • ONC-392
  • lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV infusion, Q6W for up to 6 doses.
  • (no location specified)
Dec 27, 2022

China With Non-Small-Cell Lung Cancer That is Unable to be

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    May 16, 2023

    Prophylactic Cranial Irradiation, Cumulative Incidence of Brain Metastases Trial in Guiyang (Prophylactic Cranial Irradiation

    Recruiting
    • Prophylactic Cranial Irradiation, Cumulative Incidence of Brain Metastases
    • Prophylactic Cranial Irradiation for experiment arm
    • Guiyang, Guizhou, China
      Guizhou Cancer Hospital
    Aug 23, 2023

    Peripheral Intravenous Vein Catheter Phlebitis, Intravenous Infection Trial in Royal Oak (B. Braun 6.35cm 20 gauge ultralong

    Recruiting
    • Peripheral Intravenous Vein Catheter Phlebitis
    • Intravenous Infection
    • B. Braun 6.35cm 20 gauge ultralong intravenous catheter
    • BD 5.71 cm 20 gauge Accucath
    • Royal Oak, Michigan
      Beaumont Hospital - Royal Oak
    Oct 24, 2023

    Colorectal Carcinoma Trial in Guangzhou (Sintilimab, Oxaliplatin, capecitabine)

    Recruiting
    • Colorectal Carcinoma
    • Guangzhou, China
      Sun Yat-sen University
    Dec 29, 2022

    Early Tooth Exfoliation Trial in Mansoura (Fixed space maintainer)

    Completed
    • Early Tooth Exfoliation
    • Fixed space maintainer
    • Mansoura, Dakahleya Governorate, Egypt
      Department of Pediatric Dentistry, Mansoura University
    Jan 20, 2023

    Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)

    Not yet recruiting
    • Ovarian Neoplasms
    • +5 more
    • (no location specified)
    Sep 3, 2023